FORA Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $297K | Buy |
+13,746
| New | +$297K | 0.03% | 404 |
|
|
2021
Q1 | – | Sell |
-8,352
| Closed | -$446K | – | 735 |
|
|
2020
Q4 | $446K | Buy |
+8,352
| New | +$446K | 0.07% | 309 |
|
|
2020
Q3 | – | Sell |
-10,893
| Closed | -$528K | – | 622 |
|
|
2020
Q2 | $528K | Buy |
10,893
+4,168
| +62% | +$202K | 0.18% | 148 |
|
|
2020
Q1 | $284K | Buy |
6,725
+4,583
| +214% | +$194K | 0.06% | 363 |
|
|
2019
Q4 | $92K | Buy |
+2,142
| New | +$92K | 0.01% | 764 |
|